Investigating the molecular structure of plasma in type 2 diabetes mellitus and diabetic nephropathy by synchrotron Fourier-transform infrared microspectroscopy

被引:6
|
作者
Nimer, Refat [1 ]
Kamel, Gihan [2 ,3 ]
Obeidat, Motaz A. [4 ]
Dahabiyeh, Lina A. [5 ]
机构
[1] Jordan Univ Sci & Technol, Dept Med Lab Sci, Irbid 22110, Jordan
[2] SESAME Synchrotron Synchrotron Light Expt Sci & A, Allan 19252, Jordan
[3] Helwan Univ, Fac Sci, Dept Phys, Cairo, Egypt
[4] Jordan Univ Sci & Technol, Nephrol Div, Dept Internal Med, Irbid, Jordan
[5] Univ Jordan, Sch Pharm, Dept Pharmaceut Sci, Amman 11942, Jordan
关键词
T2DM; Diabetic nephropathy; Plasma; IR microspectroscopy; Lipid peroxidation; Synchrotron; CHRONIC KIDNEY-DISEASE; OXIDATIVE STRESS; LIPID-PEROXIDATION; FTIR SPECTROSCOPY; IR SPECTROSCOPY; INFLAMMATION; ASSOCIATION; DIAGNOSIS;
D O I
10.1016/j.saa.2021.120259
中图分类号
O433 [光谱学];
学科分类号
0703 ; 070302 ;
摘要
Diabetes mellitus (DM) is associated with a high incidence of morbidity and mortality which, in many cases, is derived from the progressive kidney dysfunction due to diabetic nephropathy (DN). In this study, synchrotron-Fourier-transform infrared (SR-FTIR) microspectroscopy was used to identify molecular changes in the lipid and protein regions in the plasma of patients with different stages of DN (mild, moderate, severe and end-stage), and patients with type 2 diabetes mellitus (T2DM) without DN. Our results revealed different conformational changes in the proteins secondary structure between DN stages, and between DN and T2DM groups illustrated by peak shifts and intensity alterations. End-stage DN showed the highest CH2/CH3 ratio and intensity of the carbonyl group in protein-carbonyl region compared to other DN stages indicating high level of unsaturation and lipid peroxidation and oxidation conditions. Moreover, end-stage DN group was characterized by a decrease in amide I and amide II absorption signals which reflected a sign of hypoalbuminemia. When compared to T2DM, DN group demonstrated a higher oxidation state as confirmed via the high intensity of the carbonyl group and the high level of malondialdehyde. The current study highlights the promising role of SR-FTIR microspectroscopy as a new sensitive analytical approach that can be used to provide better understanding of the pathophysiology of DN, and guide the development of new preventive therapies and treatments. (C) 2021 Elsevier B.V. All rights reserved.
引用
收藏
页数:9
相关论文
共 50 条
  • [21] Evidence for a stem-cell lineage in human intestinal adenocarcinoma using synchrotron radiation-based Fourier-transform infrared microspectroscopy
    Ahmadzai, Abdullah A.
    Patel, Imran I.
    Llabjani, Valon
    Martin, Francis L.
    MUTAGENESIS, 2012, 27 (06) : 801 - 801
  • [22] Urine and plasma metabolites predict the development of diabetic nephropathy in individuals with Type 2 diabetes mellitus
    Pena, M. J.
    Heerspink, H. J. Lambers
    Hellemons, M. E.
    Friedrich, T.
    Dallmann, G.
    Lajer, M.
    Bakker, S. J. L.
    Gansevoort, R. T.
    Rossing, P.
    de Zeeuw, D.
    Roscioni, S. S.
    DIABETIC MEDICINE, 2014, 31 (09) : 1138 - 1147
  • [23] Plasma sTNFR1 levels and incipient diabetic nephropathy in type 2 diabetes mellitus
    Mauri, JM
    Ricart, W
    Vallés, M
    Gutiérrez, C
    Vendrell, J
    Fernández-Real, JM
    DIABETOLOGIA, 1999, 42 : A273 - A273
  • [24] Plasma and urinary vascular endothelial growth factor and diabetic nephropathy in Type 2 diabetes mellitus
    Kim, NH
    Kim, KB
    Kim, DL
    Kim, SG
    Choi, KM
    Baik, SH
    Choi, DS
    Kang, YS
    Han, SY
    Han, KH
    Ji, YH
    Cha, DR
    DIABETIC MEDICINE, 2004, 21 (06) : 545 - 551
  • [25] Phospholipidomic identification of potential plasma biomarkers associated with type 2 diabetes mellitus and diabetic nephropathy
    Zhu, Chao
    Liang, Qiong-lin
    Hu, Ping
    Wang, Yi-ming
    Luo, Guo-an
    TALANTA, 2011, 85 (04) : 1711 - 1720
  • [26] Plasma bradykinin and early diabetic nephropathy lesions in type 1 diabetes mellitus
    Wheelock, Kevin M.
    Cai, Jian
    Looker, Helen C.
    Merchant, Michael L.
    Nelson, Robert G.
    Fufaa, Gudeta D.
    Weil, E. Jennifer
    Feldman, Harold I.
    Vasan, Ramachandran S.
    Kimmel, Paul L.
    Rovin, Brad H.
    Mauer, Michael
    Klein, Jon B.
    PLOS ONE, 2017, 12 (07):
  • [27] THE CONCORDANCE BETWEEN DIABETIC NEPHROPATHY AND RETINOPATHY IN TYPE 2 DIABETES MELLITUS
    Rajiv, A.
    NEPHROLOGY, 2016, 21 : 58 - 58
  • [28] Synchrotron Fourier-transform infrared microspectroscopy: Characterization of tumor infiltrating monocytes stimulated by the secretome of inflammatory and non-inflammatory breast cancer cells
    Mohamed, Hossam T.
    Kamel, Gihan
    El-Sharkawy, Aya A.
    El-Husseiny, Noura
    El-Shinawi, Mohamed
    Mohamed, Mona M.
    CANCER RESEARCH, 2022, 82 (12)
  • [29] THE CORRELATION BETWEEN DEPRESSION AND DIABETIC NEPHROPATHY IN TYPE 2 DIABETES MELLITUS
    Themeli, Y.
    Aliko, I.
    Hashorva, A.
    Bajrami, V.
    Idrizi, A.
    Barbullushi, M.
    Ktona, E.
    EUROPEAN PSYCHIATRY, 2012, 27
  • [30] Progression of diabetic nephropathy in Saudi patients with type 2 diabetes mellitus
    Al Suleiman, Mohamed H.
    Kfoury, Hala K.
    Jondeby, Mohamed S.
    Burgos, Noel S.
    Al Hayyan, Hajjar
    Al Sayyari, Abdulla
    ENDOCRINOLOGIST, 2008, 18 (05): : 230 - 232